Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cannabinoid modulation of neuroinflammatory disorders.
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Advances of Molecular Imaging for Monitoring the Anatomical and Functional Architecture of the Olfactory System.
2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Inhibits Microglial Proliferation and Activation via an Estrogen Receptor-Independent Mechanism.
Microbial view of central nervous system autoimmunity.
Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report.
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Expression of Lymphatic Markers in the Adult Rat Spinal Cord.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
Improving drug delivery technology for treating neurodegenerative diseases.
Cellular senescence and the aging brain.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
Decreased serum vitamin D levels in Japanese patients with multiple sclerosis.
A New Zealand pilot randomized controlled trial of a web-based interactive self-management programme (MSInvigor8) with and without email support for the treatment of multiple sclerosis fatigue.
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Primary progressive multiple sclerosis: progress and challenges.
Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study.
Pages
« first
‹ previous
…
495
496
497
498
499
500
501
502
503
…
next ›
last »